Ligand Pharmaceuticals LGND Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's pre-tax income?
- Ligand Pharmaceuticals (LGND) reported pre-tax income of -$24.26M in Q1 2026.
- How has Ligand Pharmaceuticals's pre-tax income changed year-over-year?
- Ligand Pharmaceuticals's pre-tax income increased by 51.7% year-over-year, from -$50.18M to -$24.26M.
- What is the long-term trend for Ligand Pharmaceuticals's pre-tax income?
- Over 3 years (2021 to 2025), Ligand Pharmaceuticals's pre-tax income has grown at a 30.1% compound annual growth rate (CAGR), from $72.21M to $158.96M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.